BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Amide compounds for treatment of immune and inflammatory disordersBDB
Achillion Pharmaceuticals
Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBDB
Bristol-Myers Squibb
Benzoisothiazole compounds and methods of treating schizophreniaBDB
Shanghai Institute of Pharmaceutical Industry
Substituted benzamides and methods of use thereofBDB
Genentech
Compounds and methods for skin repairBDB
Allergan
Heterocyclic derivatesBDB
Kalvista Pharmaceuticals
Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.BDB
Upjohn
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors.BDB
Merck Research Laboratories
Design and synthesis of potent C(2)-symmetric diol-based HIV-1 protease inhibitors: effects of fluoro substitution.BDB
Linkoping University